People
Akelos Inc., a biotechnology company currently developing and commercializing a novel, non-opioid anti-hyperalgesic drug to treat chronic and neuropathic pain, adds Dr. Charles Berde to its Scientific Advisory Board.
Fusion Antibodies plc announces that Dr Paul Kerr, Chief Executive Officer of the Company, has purchased 1,290 ordinary shares in the Company at a price of 77 pence per Ordinary Share.
Polarean Imaging plc announces the appointment of Charles Osborne, Jr as Chief Financial Officer with immediate effect.
The Biotechnology Innovation Organization (BIO) announced on April 16 that it was implementing a program to improve gender, racial, ethnic and LGBTQ diversity on the boards of directors, executive suites and functional leadership positions in the biopharma industry.
Motif Bio plc announced the appointment of Andrew Powell, J.D. as Non-executive Director, effective immediately.
We had the opportunity to meet with Arti Dumbrepatil, a postdoctoral fellow in the University of Michigan’s chemistry department. Arti explained her journey as an international student and how a postdoctoral fellowship can prepare you for a career as an independent scientist!
A new poll shows nearly two-thirds of people blame the pharmaceutical companies for the opioid crisis.
Akelos Inc., a biotechnology company currently developing and commercializing a novel, non-opioid anti-hyperalgesic drug to treat chronic and neuropathic pain, adds J. David Warren, Ph.D., to its Scientific Advisory Board.
DCprime announced the appointment of two highly-experienced industry veterans, Andrea van Elsas, Ph.D. and Hans Preusting, Ph.D., M.B.A, to its Supervisory Board.
Young Entrepreneur Council is an invitation-only community for the world’s most successful entrepreneurs.
PRESS RELEASES